Evaluation of Xpert<SUP>®</SUP> MTB/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of Xpert^® MTB/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis

Published:2015-10-01 Issue:10 Volume:19 Page:1216-1221
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Kim Y. W.,Seong M-W.,Kim T. S.,Yoo C-G.,Kim Y. W.,Han S. K.,Yim J-J.

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Performance of the BD MAX MDR-TB assay in a clinical setting and its impact on the clinical course of patients with pulmonary tuberculosis: a retrospective before-after study;Journal of Yeungnam Medical Science;2024-04-30

2. GeneXpert-Based Prevalence of Mycobacterium Tuberculosis and Rifampicin Resistance in Suspected Patients of District Narowal, Pakistan;J BIOL REG HOMEOS AG;2023

3. Bottlenecks and recent advancements in detecting Mycobacterium tuberculosis in patients with HIV;iLABMED;2023-05-10

4. Acid fast bacillus smear, mycobacterial culture and Xpert MTB/RIF assay for the diagnosis of tuberculous peritonitis in patients with and without end stage renal failure;Access Microbiology;2022-08-11

5. Xpert MTB/RIF Use Is Associated With Earlier Treatment Initiation and Culture Conversion Among Patients With Sputum Smear-Negative Multidrug-Resistant Tuberculosis;Open Forum Infectious Diseases;2021-11-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP